Title : Anti-EGFR and antiangiogenic monoclonal antibodies in metastatic non-small-cell lung cancer.

Pub. Date : 2016 Jun

PMID : 26950292






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Necitumumab is a new anti-EGFR monoclonal antibody that improves survival when combined to cisplatin/gemcitabine chemotherapy and has been approved in first-line advanced NSCLC. Cisplatin epidermal growth factor receptor Homo sapiens